Daunorubicin‐prednisone remission induction with hydroxyurea maintenance in acute non‐lymphocytic leukemia

Clara D. Bloomfield, Richard D. Brunning, Athanasios Theologides, B. J. Kennedy

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Forty‐five adults with acute non‐lymphocytic leukemia were treated with daunorubicin and prednisone. Twelve complete and four partial remissions were obtained. On hydroxyurea maintenance, remissions lasted a median of 6 months. The most important factors influencing remission induction were age and sex, and pretreatment absolute blast count. All 14 men over the age of 40 failed to respond while 50% of all other patients responded. Patients with low absolute blast counts were more likely to respond. A review of the literature reveals a similar overall complete remission rate of 26% using daunorubicin alone; thus adding prednisone to daunorubicin does not appear to increase the percentage of complete remissions. Hydroxyurea resulted in longer remissions than have been previously reported following daunorubicin induction; it merits further investigation as a maintenance agent.

Original languageEnglish (US)
Pages (from-to)931-938
Number of pages8
JournalCancer
Volume31
Issue number4
DOIs
StatePublished - Jan 1 1973

Fingerprint

Remission Induction
Daunorubicin
Hydroxyurea
Acute Myeloid Leukemia
Maintenance
Prednisone

Cite this

Daunorubicin‐prednisone remission induction with hydroxyurea maintenance in acute non‐lymphocytic leukemia. / Bloomfield, Clara D.; Brunning, Richard D.; Theologides, Athanasios; Kennedy, B. J.

In: Cancer, Vol. 31, No. 4, 01.01.1973, p. 931-938.

Research output: Contribution to journalArticle

Bloomfield, Clara D. ; Brunning, Richard D. ; Theologides, Athanasios ; Kennedy, B. J. / Daunorubicin‐prednisone remission induction with hydroxyurea maintenance in acute non‐lymphocytic leukemia. In: Cancer. 1973 ; Vol. 31, No. 4. pp. 931-938.
@article{1240d9fa3ba049218d5a8c1d38c75567,
title = "Daunorubicin‐prednisone remission induction with hydroxyurea maintenance in acute non‐lymphocytic leukemia",
abstract = "Forty‐five adults with acute non‐lymphocytic leukemia were treated with daunorubicin and prednisone. Twelve complete and four partial remissions were obtained. On hydroxyurea maintenance, remissions lasted a median of 6 months. The most important factors influencing remission induction were age and sex, and pretreatment absolute blast count. All 14 men over the age of 40 failed to respond while 50{\%} of all other patients responded. Patients with low absolute blast counts were more likely to respond. A review of the literature reveals a similar overall complete remission rate of 26{\%} using daunorubicin alone; thus adding prednisone to daunorubicin does not appear to increase the percentage of complete remissions. Hydroxyurea resulted in longer remissions than have been previously reported following daunorubicin induction; it merits further investigation as a maintenance agent.",
author = "Bloomfield, {Clara D.} and Brunning, {Richard D.} and Athanasios Theologides and Kennedy, {B. J.}",
year = "1973",
month = "1",
day = "1",
doi = "10.1002/1097-0142(197304)31:4<931::AID-CNCR2820310426>3.0.CO;2-E",
language = "English (US)",
volume = "31",
pages = "931--938",
journal = "Cancer",
issn = "0008-543X",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Daunorubicin‐prednisone remission induction with hydroxyurea maintenance in acute non‐lymphocytic leukemia

AU - Bloomfield, Clara D.

AU - Brunning, Richard D.

AU - Theologides, Athanasios

AU - Kennedy, B. J.

PY - 1973/1/1

Y1 - 1973/1/1

N2 - Forty‐five adults with acute non‐lymphocytic leukemia were treated with daunorubicin and prednisone. Twelve complete and four partial remissions were obtained. On hydroxyurea maintenance, remissions lasted a median of 6 months. The most important factors influencing remission induction were age and sex, and pretreatment absolute blast count. All 14 men over the age of 40 failed to respond while 50% of all other patients responded. Patients with low absolute blast counts were more likely to respond. A review of the literature reveals a similar overall complete remission rate of 26% using daunorubicin alone; thus adding prednisone to daunorubicin does not appear to increase the percentage of complete remissions. Hydroxyurea resulted in longer remissions than have been previously reported following daunorubicin induction; it merits further investigation as a maintenance agent.

AB - Forty‐five adults with acute non‐lymphocytic leukemia were treated with daunorubicin and prednisone. Twelve complete and four partial remissions were obtained. On hydroxyurea maintenance, remissions lasted a median of 6 months. The most important factors influencing remission induction were age and sex, and pretreatment absolute blast count. All 14 men over the age of 40 failed to respond while 50% of all other patients responded. Patients with low absolute blast counts were more likely to respond. A review of the literature reveals a similar overall complete remission rate of 26% using daunorubicin alone; thus adding prednisone to daunorubicin does not appear to increase the percentage of complete remissions. Hydroxyurea resulted in longer remissions than have been previously reported following daunorubicin induction; it merits further investigation as a maintenance agent.

UR - http://www.scopus.com/inward/record.url?scp=0015606237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015606237&partnerID=8YFLogxK

U2 - 10.1002/1097-0142(197304)31:4<931::AID-CNCR2820310426>3.0.CO;2-E

DO - 10.1002/1097-0142(197304)31:4<931::AID-CNCR2820310426>3.0.CO;2-E

M3 - Article

VL - 31

SP - 931

EP - 938

JO - Cancer

JF - Cancer

SN - 0008-543X

IS - 4

ER -